Mindfulness and meditation app maker Headspace is coming to Netflix next year in the form of three new television shows intended to help viewers take a breath, relax and start the new year off on the right foot.
The first series, "Headspace Guide to Meditation," will premiere globally on January 1, 2021, and will teach users the foundations of meditation. Each episode will tackle a different...
Facebook activity can be used to identify people with mood disorders and schizophrenia spectrum disorders more than a year prior to their first psychiatric hospitalization, according to research published in npj Schizophrenia.
Although these findings are not meant to substitute for clinical psychiatric assessments, the results suggest that social media data can be used in addition to clinical...
PointClickCare Technologies, a company focused on cloud-based software technology for the long-term and post-acute care market, today announced plans to acquire the cross-continuum coordinated care platform Collective Medical.
Together, the two companies will provide healthcare teams across the acute, ambulatory and post-acute care settings with access to real-time patient data at any stage of a...
The chronic condition management platform, Welldoc, has added a digital behavioral health program to its offerings.
The program was designed to help users develop skills to solve real-world problems in a structured way, Welldoc said in its announcement. It will be available as part of Welldoc’s platform for chronic conditions and population health management.
Users can get assistance in improving...
Etiometry has received 510(k) clearance from the U.S. Food and Drug Administration to add enhancements to its clinical decision support platform for the intensive care environment.
Its platform offers end-to-end data management software solutions for the collection, analysis, visualization and archiving of ICU clinical data.
With its T3 Data Aggregation and Visualization software, clinicians get...
Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes.
The FreeStyle Libre 2 system continuously measures glucose data every minute and can automatically alert users when their glucose is high or low without needing to scan the sensor.
It is worn on the back of the user’s upper arm for up to 14...
Consumer wearable devices can be key tools in predicting the onset of illnesses like COVID-19 by using health metrics like breathing rate, resting heart rate and heart rate variability (HRV), according to findings published in npj Digital Medicine from Fitbit.
The paper outlines predictors for the severity of illness, symptom prevalence, illness duration among male and female participants and...
WithMe Health, a personalized medication guidance company, has raised $20 million in a Series B funding round that closed last week. OMERS Ventures led the round, along with participation from existing investor Oak HC/FT and new investors Section 32, Shulman Ventures and MTS Ventures.
The company also brought on Michael Yang, a managing partner at OMERS Ventures, to join the WithMe Health board...
This week, the patient communication hub Well Health announced that it had secured a $45 million Series C funding round led by Lead Edge Capital.
Additional participants in the investment round were Martin Ventures, Jackson Square Ventures, Health Velocity Capital, Summation Health Ventures, Structure Capital and Freestyle Capital.
With these funds, Well Health has now raised $75 million since...
Using heart rate variability (HRV) data, wrist-worn health trackers can provide a range of predictive cardiovascular health metrics, according to a new study published in The Lancet.
The study, which was funded by Fitbit and used its smartwatches, looked at how devices continuously gathering data from the sympathetic and the parasympathetic nervous system could derive and describe diverse...
